A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen-Reference-Cited by-同舟云学术

A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen

Published:2016-04 Issue:17 Volume:291 Page:8951-8959
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Bianchi Valentina,Bulek Anna,Fuller Anna,Lloyd Angharad,Attaf Meriem,Rizkallah Pierre J.,Dolton Garry,Sewell Andrew K.,Cole David K.

Funder

Wellcome Trust

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference45 articles.

1. Human T cell responses against melanoma;Boon;Annu. Rev. Immunol,2006

2. Melanosomes: dark organelles enlighten endosomal membrane transport;Raposo;Nat. Rev. Mol. Cell Biol,2007

3. Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy;Wagner;Cancer Immunol. Immunother,1997

4. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression;Kawakami;J. Immunol,1995

5. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes;Kawakami;J. Exp. Med,1994

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New approaches to vaccines for cancer;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

2. Immune-oncological drug ipilimumab;Quantum Chemistry Methods for Oncological Drugs;2024

3. A Bibliometric Analysis of Melanoma Treated with Vaccinations Research from 2013 to 2023: A Comprehensive Review of the Literature;Vaccines;2023-06-19

4. Biomaterials Facilitating Dendritic Cell‐Mediated Cancer Immunotherapy;Advanced Science;2023-04-23

5. Tebentafusp: A novel drug for the treatment of metastatic uveal melanoma;Drugs of Today;2023-03